Legal Policy

XYNTHA (moroctocog alfa (rch) (recombinant coagulation factor VIII))
250 IU, 500 IU, 1000 IU, 2000 IU, 3000 IU

XYNTHA (moroctocog alfa (rch)) is a funded medicine that is prescribed by a doctor for the control and treatment of bleeding and the routine and surgical prevention of bleeding in patients with haemophilia A. A pharmacy charge and normal doctor’s fees apply. Xyntha has risks and benefits. XYNTHA contains trace amounts of hamster protein. You may develop an allergic reaction to these proteins. Tell your doctor if you have had an allergic reaction to hamster protein or any of the other ingredients of XYNTHA. XYNTHA must be used with caution in certain people, including: people with factor VIII inhibitors, people with allergies, people changing from other factor VIII medicines to XYNTHA, and pregnant or breastfeeding women. Ask your doctor for advice. Uncommon to very rare serious side effects include numbness, chest pain, rapid or irregular heartbeat, shortness of breath, bleeding and low blood pressure. If you have side effects see your doctor. If you suddenly experience a swollen face, lips, tongue or throat, shortness of breath, chest tightness, wheezing, dizziness, faintness, chills, flushing, tiredness, restlessness, nausea, vomiting, rapid heartbeat, headache, tingling, burning and stinging at the injection site, hives or skin rash, STOP taking XYNTHA and seek urgent medical attention. These may be signs of a serious allergic reaction. Tell your doctor immediately if you are using increasing amounts of XYNTHA in order to control a bleeding episode. Use strictly as directed. Consult your doctor to see if XYNTHA is right for you. Contains moroctocog alfa (rch) 250, 500, 1000, 2000, 3000 IU/vial or syringe.

Further information on XYNTHA is available from www.medsafe.govt.nz or Pfizer New Zealand Limited, Auckland, www.pfizer.co.nz. Ph. 0800 736 363. V11216 Pfizer New Zealand, Level 1, Suite 1.4, Building B, 8 Nugent Street, Grafton, Auckland 1023. PPZR0332 PP-XYN-NZL-0063, NA 9403 09/17.

XYNTHA® is a registered trademark.
© Pfizer 2017

www.medsafe.govt.nz

www.haemophilia.org.nz

© 2017 Pfizer New Zealand Limited, Auckland. All rights reserved.